Nanosized, with huge potential
July 8, 2020
Xiaoyang Qi, PhD, received a $500,000 PanCAN grant to study ways a combination therapy could nudge the immune system to fight pancreatic cancer.
InStyle: Top 50 health care workers who are saving the day
July 9, 2020
UC's Trisha Wise-Draper, MD, PhD, has been named one of InStyle Magazine's "Badass 50" health care providers making a difference during the pandemic.
UC research: Immunotherapy safe for patients with COVID-19, cancer
July 20, 2020
Preliminary data from researchers at the University of Cincinnati Cancer Center show that immunotherapy doesn’t necessarily worsen complications for patients with both COVID-19 and cancer.
UC researchers to study drug’s effects on COVID-19 patients
September 22, 2020
Researchers at the University of Cincinnati and UC Health will host a Phase 2 clinical trial (NCT04511650) to examine the effects of a drug that targets blood vessel inflammation and injury in patients with COVID-19. They will study the effects of razuprotafib, an investigational drug that activates a key pathway for stabilizing blood vessels in the lung and other organs in patients with moderate to severe cases of the respiratory illness caused by the novel coronavirus SARS-CoV-2. The drug may prevent and treat respiratory distress in COVID-19 patients. The Phase 2 clinical trial will assess safety, tolerability and efficacy of razuprotafib.
WCPO: Raising colorectal cancer awareness
September 2, 2020
Olugbenga Olowokure, MD, says it can be difficult to detect colon cancer in someone younger than 45 years old, which is when screenings are recommended.